Osteogenic Differentiation in Chitosan-Based Scaffolds via P28 and VEGF Delivery
Open Access
- 7 September 2025
- Vol. 30 (17) , 3645
Abstract
Repairing large bone defects remains a significant clinical challenge due to the limitations of current treatments, including infection risk, donor site morbidity, and insufficient vascularization. The autograft is still the gold standard for large bone defects. In this study, we developed chitosan-based (CS-based) scaffolds, incorporating with hydroxyapatite (HAp) and fluorapatite (FAp) ceramics, fabricated by UV crosslinking and freeze-drying, and loaded with P28 peptide, alone or in combination with vascular endothelial growth factor (VEGF), to evaluate the effect of dual bioactive factor delivery. We hypothesized that CS-based scaffolds would optimize ceramic composition and co-delivery of P28 and VEGF, and can enhance early-stage osteogenic differentiation and support bone regeneration. The CS-based scaffolds were characterized by their physicochemical properties, including swelling behavior, mechanical strength, porosity, and in vitro degradation. Biological evaluations were performed including cell proliferation assays, ALP activity, ARS staining, and RT-qPCR, to assess osteogenic differentiation. The results showed that the scaffolds had high porosity, excellent swelling behavior, and degraded within 8 weeks. Dual delivery of P28 and VEGF significantly enhanced early osteogenic markers, indicating a complementary effect. These findings demonstrated that CS-based scaffolds with an optimized ceramic ratio and bioactive factor incorporation have the potential to facilitate bone regeneration.Keywords
Funding Information
- Technological University of The Shannon through the President’s Seed Fund (PC00026, CF20160600)
- Enterprise Ireland Commercialization Fund (PC00026, CF20160600)
This publication has 87 references indexed in Scilit:
- The decisive early phase of biomaterial-induced bone regenerationApplied Materials Today, 2024
- Manufacturing of scaffolds with interconnected internal open porosity and surface roughnessActa Biomaterialia, 2022
- Biomaterials and nanomedicine for bone regeneration: Progress and future prospectsExploration, 2021
- Chitosan/hydroxyapatite nanocomposite scaffolds to modulate osteogenic and inflammatory responseJournal of Biomedical Materials Research Part A, 2021
- Mechanical and in vitro biological properties of uniform and graded Cobalt‐chrome lattice structures in orthopedic implantsJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2021
- Scaffold Fabrication Technologies and Structure/Function Properties in Bone Tissue EngineeringAdvanced Functional Materials, 2021
- Induction of Bone Formation by 3D Biologically Active Scaffolds Containing RGD‐NPs, BMP2, and NtMPCsAdvanced Therapeutics, 2021
- Sustained delivery of vascular endothelial growth factor from mesoporous calcium‐deficient hydroxyapatite microparticles promotes in vitro angiogenesis and osteogenesisJournal of Biomedical Materials Research Part A, 2020
- Modulating the mechanical properties of photopolymerised polyethylene glycol–polypropylene glycol hydrogels for bone regenerationJournal of Materials Science, 2012
- How useful is SBF in predicting in vivo bone bioactivity?Biomaterials, 2006